| Literature DB >> 32993801 |
Karson T F Kung1,2,3.
Abstract
BACKGROUND: Prior research examining autistic traits in gender minority adults has reported mixed findings. Most prior studies did not include non-binary individuals. Little is known about the mechanisms shaping autistic traits in gender minority adults. This study examined autistic traits, as well as constructs related to the extreme male brain theory of autism and the mindblindness theory, in transgender and non-binary adults.Entities:
Keywords: Autism; Empathy; Extreme male brain; Gender minority; Non-binary; Systemising; Theory of mind; Transgender
Mesh:
Year: 2020 PMID: 32993801 PMCID: PMC7523342 DOI: 10.1186/s13229-020-00378-7
Source DB: PubMed Journal: Mol Autism Impact factor: 7.509
Sample sizes, measures, and descriptive statistics for the current study and the general population studies
| AQ | SQ-Short | EQ-Short | EQ-10 | Eyes Test | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||||||
| Current study | ||||||||||
| Transgender men | 72 | 22.98 (9.02) | 72 | 20.83 (9.45) | 72 | 20.11 (10.90) | 72 | 8.38 (5.21) | 74 | 26.57 (4.80) |
| Non-binary AFAB | 98 | 26.55 (8.38) | 97 | 21.28 (9.81) | 97 | 19.50 (10.71) | 97 | 8.33 (4.98) | 104 | 26.73 (4.20) |
| Transgender women | 90 | 20.37 (7.76) | 89 | 23.64 (10.01) | 89 | 23.96 (9.54) | 89 | 10.50 (4.80) | 95 | 26.25 (3.58) |
| Non-binary AMAB | 48 | 22.00 (7.05) | 47 | 22.85 (9.75) | 47 | 23.21 (9.42) | 47 | 10.30 (4.31) | 50 | 26.95 (4.22) |
| Baron-Cohen et al. [ | ||||||||||
| Females | 2562 | 17.1 (7.6) | – | – | – | – | – | – | – | |
| Males | 1344 | 20.3 (7.8) | – | – | – | – | – | – | – | – |
| Ruzich et al. [ | ||||||||||
| Females | 298,084 | 18.95 (8.52) | – | – | – | – | – | – | – | – |
| Males | 152,310 | 21.55 (8.82) | – | – | – | – | – | – | – | – |
| Wakabayashi et al. [ | ||||||||||
| Females | – | – | 1038 | 15.4 (8.77) | 1038 | 26.0 (8.27) | – | – | – | – |
| Males | – | – | 723 | 24.1 (9.55) | 723 | 20.7 (8.46) | – | – | – | – |
| Greenberg et al. [ | ||||||||||
| Females | – | – | – | – | – | – | 412,062 | 10.79 (4.84) | – | – |
| Males | – | – | – | – | – | – | 259,544 | 8.87 (4.75) | – | – |
| Warrier et al. [ | ||||||||||
| Females | – | – | – | – | – | – | – | – | 44,574 | 27.85 (3.55) |
| Males | – | – | – | – | – | – | – | – | 43,482 | 27.08 (3.75) |
AFAB = individuals assigned female at birth; AMAB = individuals assigned male at birth. The variation in decimal places reported in the table reflects differing report styles across published studies
Inferential statistics and effect sizes for the group comparisons
| Comparison | Measure and control study | Direction of Effect | Cohen’s | 95% CI for | ||
|---|---|---|---|---|---|---|
| Transgender men vs. control females | AQ (vs. Baron-Cohen et al.) [ | Transgender men > control females | 5.54 | < 0.001 | 0.77 | [0.53, 1.00] |
| AQ (vs. Ruzich et al.) [ | Transgender men > control females | 3.80 | < 0.001 | 0.47 | [0.24, 0.70] | |
| SQ-Short [ | Transgender men > control females | 4.88 | < 0.001 | 0.62 | [0.38, 0.86] | |
| EQ-Short [ | Transgender men < control females | − 4.58 | < 0.001 | − 0.70 | [− 0.94, − 0.46] | |
| EQ-10 [ | Transgender men < control females | − 3.93 | < 0.001 | − 0.50 | [− 0.73, − 0.25] | |
| Eyes Test [ | Transgender men < control females | − 2.29 | 0.025 | − 0.36 | [− 0.59, − 0.13] | |
| Non-binary AFAB vs. control females | AQ (vs. Baron-Cohen et al.) [ | Non-binary AFAB > control females | 11.16 | < 0.001 | 1.24 | [1.03, 1.44] |
| AQ ( vs. Ruzich et al.) [ | Non-binary AFAB > control females | 8.98 | < 0.001 | 0.89 | [0.69, 1.09] | |
| SQ-Short [ | Non-binary AFAB > control females | 5.90 | < 0.001 | 0.66 | [0.45, 0.87] | |
| EQ-Short [ | Non-binary AFAB < control females | − 5.98 | < 0.001 | − 0.76 | [− 0.97, − 0.55] | |
| EQ-10 [ | Non-binary AFAB < control females | − 4.86 | < 0.001 | − 0.51 | [− 0.71, − 0.31] | |
| Eyes Test [ | Non-binary AFAB < control females | − 2.72 | 0.008 | − 0.32 | [− 0.51, − 0.12] | |
| Transgender women vs. control males | AQ (vs. Baron-Cohen et al.) [ | Transgender women > control males | 0.84 | 0.993 | 0.01 | [− 0.20, 0.22] |
| AQ (vs. Ruzich et al.) [ | Transgender women < control males | − 1.44 | 0.152 | − 0.13 | [− 0.34, 0.07] | |
| SQ-Short [ | Transgender women < control males | − 0.43 | 0.666 | − 0.05 | [− 0.27, 0.17] | |
| EQ-Short [ | Transgender women > control males | 3.22 | 0.002 | 0.38 | [0.16, 0.60] | |
| EQ-10 [ | Transgender women > control males | 3.21 | 0.002 | 0.34 | [0.14, 0.55] | |
| Eyes Test [ | Transgender women < control males | − 2.27 | 0.026 | − 0.22 | [− 0.42, − 0.02] | |
| Non-binary AMAB vs. control males | AQ (vs. Baron-Cohen et al.) [ | Non-binary AMAB > control males | 1.67 | 0.102 | 0.22 | [− 0.07, 0.51] |
| AQ (vs. Ruzich et al.) [ | Non-binary AMAB > control males | 0.44 | 0.661 | 0.05 | [− 0.23, 0.33] | |
| SQ-Short [ | Non-binary AMAB < control males | − 0.88 | 0.384 | − 0.13 | [− 0.43, 0.16] | |
| EQ-Short [ | Non-binary AMAB > control males | 1.83 | 0.074 | 0.29 | [− 0.00, 0.59] | |
| EQ-10 [ | Non-binary AMAB > control males | 2.27 | 0.028 | 0.30 | [0.02, 0.59] | |
| Eyes Test [ | Non-binary AMAB < control males | − 0.21 | 0.832 | − 0.03 | [− 0.31, 0.24] |
AFAB = individuals assigned female at birth; AMAB = individuals assigned male at birth
Descriptive statistics of “brain types” in the current sample and in Wakabayashi et al. [31]
| Extreme Type E | Type E | Type B | Type S | Extreme Type S | |
|---|---|---|---|---|---|
| Transgender men | 6.9% ( | 11.1% ( | 43.1% ( | 16.7% ( | 22.2% ( |
| Non-binary AFAB | 3.1% ( | 7.2% ( | 49.5% ( | 16.5% ( | 23.7% ( |
| Control females [ | 15.4% ( | 25.9% ( | 46.6% ( | 8.5% ( | 3.6% ( |
| Transgender women | 4.5% ( | 16.9% ( | 41.6% ( | 21.3% ( | 15.7% ( |
| Non-binary AMAB | 2.1% ( | 10.6% ( | 59.6% ( | 17.0% ( | 10.6% ( |
| Control males [ | 1.4% ( | 5.8% ( | 45.9% ( | 24.1% ( | 22.8% ( |
Extreme Type E = Much stronger empathising relative to systemising; Type E = Stronger empathising relative to systemising; Type B = Balanced; similar levels of systemising and empathising; Type S = Stronger systemising relative to empathising; Extreme Type S = Much stronger systemising relative to empathising